SpaceX made history on June 12, 2026, with the largest initial public offering (IPO) ever recorded, raising $75 billion at a fixed price of $135 per share. When SPCX opened for trading on the Nasdaq that morning, the first print was $150 — a level that instantly became embedded in the market's memory. Shares closed their debut session at $160.95 and surged as high as $225.64 within days. Less than two months later, the stock has surrendered all of those early gains, closing at $108.37 on July 31 and touching an intraday low of $107.01 during the week.
For many investors, $150 is not just a round number. It represents the initial public market validation of SpaceX's enormous private-market valuation. Reclaiming that level would signal that the post-IPO sell-off has fully reversed and that buyer conviction has returned. It is also a price mentioned repeatedly in analyst notes as a logical first upside target on any sustained recovery.
SpaceX operates across three segments: Space (launch services using Falcon 9 and Falcon Heavy rockets), Connectivity (the Starlink satellite internet business), and AI (following the acquisition of xAI, which includes the Grok large language model and the Colossus data center). The company generated trailing twelve-month revenue of approximately $19.3 billion, reflecting 33% year-over-year growth, but remains deeply unprofitable with a net loss of $9.36 billion and negative earnings per share (EPS) of -$2.94.
Several converging pressures have pushed SPCX lower. The stock's tiny public float — only about 4% to 5% of total shares outstanding were sold in the IPO — amplified both the initial rally and the subsequent decline. The impending August 4 earnings report, the company's first as a public entity, has introduced uncertainty. Even more significant is the August 6 lockup expiration, which could release up to 911.5 million shares held by employees and early investors into the market. The all-stock $60 billion acquisition of Cursor has added dilution concerns. Meanwhile, Starship's 13th test flight produced mixed results, reminding investors that the company's most ambitious engineering milestones remain works in progress. I also checked this using Tickeron’s AI Pattern Search Engine to see how the post-IPO pattern compares to similar debut situations.
A return to $150 is far from theoretical. The consensus analyst price target of $236.71 — based on 34 analysts — implies that Wall Street expects SPCX to trade well above $150 within the next twelve months. Several tangible catalysts could fuel such a recovery.
First, Starlink continues to scale. The satellite internet business generated $11.4 billion in revenue in 2025 and served approximately 10.3 million subscribers across 164 countries as of March 2026. While average revenue per user has compressed, the sheer pace of subscriber growth provides a recurring revenue foundation that few competitors can match. Second, SpaceX's AI compute segment is gaining traction. The company signed a contract with Anthropic worth $1.25 billion per month through May 2029 for compute capacity. Third, SpaceX's dominant position in commercial launch — it captured 82% of the U.S. commercial launch market in 2025 — gives it a wide economic moat that supports long-term revenue visibility. The U.S. Space Force recently awarded SpaceX a $1.6 billion contract for 18 Falcon 9 launches through 2027.
Additionally, prominent institutional investors continue to express conviction. Cathie Wood's ARK Invest has been buying SPCX shares throughout the decline. Billionaire investor Ron Baron, who holds one of the largest SpaceX stakes among public fund managers, has predicted the company could eventually be worth trillions more than its current market capitalization.
The obstacles are substantial. The August 6 lockup expiration is the most immediate concern. Even if only a fraction of the 911.5 million newly eligible shares are sold, the additional supply could overwhelm demand in a market where the float is already thin. More lockup expirations are scheduled in the months ahead, with Elon Musk's own shares not fully unlocking until mid-2027.
Valuation remains a persistent headwind. At $108.37, SPCX still trades at roughly 74 times trailing sales, an exceptionally rich multiple for a company that is not yet profitable. Morningstar, which published a pre-IPO fair value estimate of $63 per share, has maintained its skeptical stance, arguing that the market is pricing in unproven outcomes across Starship, orbital AI data centers, and interplanetary ambitions.
Competition is intensifying. AMZN subsidiary Project Kuiper seeks FCC approval to launch over 5,000 broadband satellites, directly challenging Starlink's market. In the AI space, xAI's Grok model trails MSFT-backed OpenAI's ChatGPT and Anthropic's Claude in both user metrics and market mindshare, raising questions about the segment's ability to drive outsized revenue growth.
The analyst community is broadly constructive but far from unanimous. Of the 34 analysts covering SPCX, the consensus rating is "Buy" with an average twelve-month price target of $236.71 — more than double the current price. Morgan Stanley's Adam Jonas holds an Overweight rating with a $300 target, arguing that at current levels the market is assigning almost no value to SpaceX's AI business. Goldman Sachs, JPMorgan, Bank of America, and Deutsche Bank have all issued Buy-equivalent ratings with targets clustered between $200 and $255. Cantor Fitzgerald recently reaffirmed a $246 target ahead of earnings.
On the more cautious side, CFRA initiated coverage with a Sell rating and a $115 target, while MoffettNathanson set the Street-low target at $131 with a Neutral rating. Morningstar's fair value estimate of $62 remains the most bearish published figure. The wide dispersion — from $62 to $800 — reflects genuine uncertainty about which parts of SpaceX's ambitious roadmap will materialize and when.
SPCX remains in a clear downtrend, with its five-day and twenty-day moving averages both sloping lower. The $107–$108 zone has emerged as immediate support, with the psychologically significant $100 level representing the next downside marker if that floor gives way. On the upside, SPCX must first recover the $112–$114 area, where the 50-period exponential moving average sits, before mounting any credible challenge to higher levels. A move through $120 would likely attract momentum-driven buyers. The $135 IPO price then becomes the next major hurdle before $150 comes into view. A sustained break above $150 would mark the stock's first higher high since mid-June and would meaningfully shift the technical narrative from bearish to neutral or improving.
A return to $150 for SpaceX stock is a realistic medium-term scenario, but it is unlikely to happen without clearing several near-term hurdles. The strongest arguments in favor are the overwhelming Wall Street consensus that SPCX is undervalued at current levels, Starlink's expanding subscriber base, growing AI compute revenue, and SpaceX's dominant competitive position in launch services. The most formidable obstacles are the August 6 lockup expiration, the company's lack of profitability, an elevated valuation multiple, and technical damage that will take time to repair. Investors should monitor the upcoming earnings report on August 4 for clarity on revenue trajectory and margin trends, observe how the market absorbs the post-lockup share supply, and watch whether SPCX can establish a sustainable base above the $107–$108 support zone. In a best-case scenario, strong earnings and manageable insider selling could pave the way for a gradual recovery toward $135 and then $150 over the coming quarters. In a more challenging scenario, additional selling pressure could test the $100 level before any meaningful rebound takes hold.
In my own research on volatile names like SPCX, I have turned to Tickeron's AI Daily Buy/Sell Signals to monitor momentum shifts and generate timely alerts. The tool scans thousands of stocks and ETFs using AI to produce Buy, Sell, or Hold signals based on technical patterns and evolving conditions. It adds a useful layer of data-driven insight that complements fundamental work, especially during periods of high uncertainty such as lockup expirations and first earnings reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SPCX moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 77 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 44%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 15 of 57 cases where SPCX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 26%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPCX as a result. In 35 of 126 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 28%.
The Moving Average Convergence Divergence Histogram (MACD) for SPCX turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 61 similar instances when the indicator turned negative. In 19 of the 61 cases the stock turned lower in the days that followed. This puts the odds of success at 31%.
The 10-day moving average for SPCX crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 18%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 30%.
The Aroon Indicator for SPCX entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Following a +4.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPCX advanced for three days, in 27 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 15%.
SPCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SPCX's P/B Ratio (13.912) is slightly higher than the industry average of (5.050). SPCX has a moderately low P/E Ratio (-122.064) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (69.444) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SPCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense